Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendrimers | 9 | 2021 | 11 | 3.010 |
Why?
|
| Drug Delivery Systems | 7 | 2021 | 178 | 1.960 |
Why?
|
| Spheroids, Cellular | 2 | 2019 | 31 | 1.240 |
Why?
|
| Neoplasms | 9 | 2023 | 2898 | 1.020 |
Why?
|
| Drug Carriers | 5 | 2016 | 82 | 0.880 |
Why?
|
| Nanoparticles | 6 | 2022 | 157 | 0.750 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 30 | 0.690 |
Why?
|
| Gold | 1 | 2019 | 41 | 0.680 |
Why?
|
| Polymers | 2 | 2015 | 202 | 0.570 |
Why?
|
| Polyamines | 1 | 2016 | 32 | 0.540 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 106 | 0.310 |
Why?
|
| Drug Design | 2 | 2015 | 124 | 0.250 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 301 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2016 | 534 | 0.200 |
Why?
|
| Erythroid Precursor Cells | 1 | 2021 | 32 | 0.190 |
Why?
|
| Tretinoin | 1 | 2021 | 126 | 0.190 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2426 | 0.190 |
Why?
|
| Probiotics | 1 | 2021 | 81 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2023 | 445 | 0.180 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 301 | 0.170 |
Why?
|
| Nanostructures | 2 | 2017 | 77 | 0.170 |
Why?
|
| Particle Size | 2 | 2016 | 122 | 0.160 |
Why?
|
| Membrane Proteins | 3 | 2023 | 1196 | 0.160 |
Why?
|
| Macrophages | 1 | 2021 | 557 | 0.160 |
Why?
|
| Tissue Distribution | 2 | 2015 | 290 | 0.150 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 24 | 0.150 |
Why?
|
| Melanoma | 1 | 2021 | 459 | 0.140 |
Why?
|
| Animals | 11 | 2023 | 26590 | 0.140 |
Why?
|
| KB Cells | 1 | 2016 | 2 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 152 | 0.140 |
Why?
|
| Cations | 1 | 2016 | 30 | 0.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 90 | 0.140 |
Why?
|
| Humans | 14 | 2023 | 86656 | 0.130 |
Why?
|
| Nanotechnology | 1 | 2016 | 68 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 157 | 0.130 |
Why?
|
| Leukemia, Myeloid | 1 | 2016 | 249 | 0.130 |
Why?
|
| Mice | 7 | 2023 | 11356 | 0.120 |
Why?
|
| Lactates | 1 | 2014 | 37 | 0.120 |
Why?
|
| Folic Acid | 1 | 2014 | 60 | 0.120 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2014 | 147 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 938 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 364 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2023 | 249 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 763 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 418 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2231 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2360 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2022 | 27 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2023 | 98 | 0.060 |
Why?
|
| Zinc | 1 | 2022 | 92 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2022 | 273 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1047 | 0.050 |
Why?
|
| Micelles | 1 | 2021 | 47 | 0.050 |
Why?
|
| Receptors, CCR2 | 1 | 2021 | 35 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2021 | 168 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2021 | 175 | 0.050 |
Why?
|
| Lipids | 1 | 2021 | 269 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 164 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 429 | 0.040 |
Why?
|
| Transfection | 1 | 2021 | 896 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2023 | 3243 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 684 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 444 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 425 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 503 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 558 | 0.040 |
Why?
|
| Surface Properties | 1 | 2017 | 130 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1924 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2017 | 287 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1565 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 629 | 0.030 |
Why?
|
| DNA | 1 | 2021 | 1294 | 0.030 |
Why?
|
| Folic Acid Transporters | 1 | 2014 | 1 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 1921 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 506 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2014 | 14 | 0.030 |
Why?
|
| Fluorescein | 1 | 2014 | 16 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2014 | 14 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 826 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2014 | 30 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 615 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 59 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 346 | 0.030 |
Why?
|
| Ovary | 1 | 2014 | 258 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 790 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 481 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 736 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 2469 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 969 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1384 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1579 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3095 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 744 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 3968 | 0.020 |
Why?
|
| Female | 2 | 2014 | 44547 | 0.010 |
Why?
|